Limulus polyphemus (LPA) (AP)
Catalog No : USB-L2275-36C
613.81€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Limulus polyphemus (LPA) (AP) | ||
|---|---|---|---|
| Catalog No | USB-L2275-36C | ||
| Supplier’s Catalog No | L2275-36C | ||
| Supplier | US Biologicals | ||
| Source antigen | |||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | 4°C Do Not Freeze | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified | ||
| Form | Supplied as a liquid in 0.05M Tris, 0.3M sodium chloride, 0.01M calcium chloride, pH 8.0, 20-50% glycerol. Labeled with Alkaline Phosphatase (AP). | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified | ||
| Description | Pure Limulus polyphemus lectin (LPA) from horseshoe crab, Alkaline Phosphatase conjugated. Lectins are derived from the extracts of plants, animals, viruses and microorganisms and are known to agglutinate red blood cells. These agglutinins can select cell types according to blood group activities utilizing sugar-binding mechanisms. Lectins form precipitates with glycoconjugates and are useful for identifying or separating oligosaccharides with identical sugar compositions such as galactose, mannose or glucose. Carbohydrate Specificity: Sialic Acid (N-Acetyl neuraminic acid) Inhibitory Carbohydrate: N-Acetylneuraminic acid and N-Glycolylneuraminic acid Activity: 10-20ug/ml will agglutinate type O human erythrocytes. As much as 100ug/ml may be necessary to agglutinate type A or B cells. Chemical Used for Conjugation: Alkaline Phosphatase. Storage and Stability: May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Freezing alkaline phosphatase conjugates will result in a substantial loss of enzymatic activity. | ||
© 2020 Imugex All Rights Reserved